CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 19 filers reported holding CERULEAN PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $37,000 | -48.6% | 85,442 | -4.5% | 0.00% | – |
| Q1 2017 | $72,000 | +16.1% | 89,463 | +0.6% | 0.00% | – |
| Q4 2016 | $62,000 | -31.1% | 88,917 | +0.4% | 0.00% | – |
| Q3 2016 | $90,000 | -51.9% | 88,553 | +0.1% | 0.00% | – |
| Q2 2016 | $187,000 | -21.8% | 88,462 | 0.0% | 0.00% | – |
| Q1 2016 | $239,000 | -3.2% | 88,462 | -0.1% | 0.00% | – |
| Q4 2015 | $247,000 | -23.5% | 88,553 | +0.2% | 0.00% | – |
| Q3 2015 | $323,000 | -20.2% | 88,371 | +0.2% | 0.00% | – |
| Q2 2015 | $405,000 | +15.1% | 88,189 | +125.1% | 0.00% | – |
| Q1 2015 | $352,000 | +127.1% | 39,169 | +56.6% | 0.00% | – |
| Q4 2014 | $155,000 | +96.2% | 25,014 | +32.5% | 0.00% | – |
| Q3 2014 | $79,000 | – | 18,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |